{
    "clinical_study": {
        "@rank": "21532", 
        "acronym": "FIN3002", 
        "arm_group": [
            {
                "arm_group_label": "Gonal-f RFF", 
                "arm_group_type": "Active Comparator", 
                "description": "One subcutaneous injection of 225IU Gonal-f (follitropin-alfa) per day (initial dose) for the first 6 days. Increase of dose to a maximum of 450IU per day after initial dosing period if deemed necessary"
            }, 
            {
                "arm_group_label": "AFOLIA", 
                "arm_group_type": "Experimental", 
                "description": "One subcutaneous injection of 225IU AFOLIA (follitropin-alfa) per day (initial dose) for the first 6 days. Increase of dose to a maximum of 450IU per day after initial dosing period if deemed necessary"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to show that AFOLIA, a recombinant manufactured human follicle\n      stimulating hormone (r-hFSH) has a similar efficacy and safety profile compared to the\n      widely used and marketed r-hFSH Gonal-f."
        }, 
        "brief_title": "A Phase III Study to Compare Efficacy and Safety of AFOLIA vs. Gonal-f\u00ae in Infertile Women 35 to 42 Years of Age Undergoing in Vitro Fertilization (IVF)", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "detailed_description": {
            "textblock": "Comparison of the clinical pregnancy rate in the AFOLIA group compared to the Gonal-f group\n      as the primary endpoint. Comparison of the number and size of follicles, the number of cycle\n      cancellation, the hormone parameters and adverse events in the AFOLIA group compared to the\n      Gonal-f group as secondary endpoints."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  35 to 42 years of age\n\n          -  Indication for controlled ovarian stimulation and IVF or intracytoplasmic sperm\n             injection (ICSI)\n\n          -  Regular menstrual cycles (25-35 days)\n\n          -  History of a maximum of two fresh cycle treatments in the present series of assisted\n             reproductive   technologies (ART) at the day of first screening (thawed cycles are\n             not subject to that criteria)\n\n          -  Body mass index (BMI) \u226518 and \u226438 kg/m2\n\n          -  Basal FSH <12 IU/L (cycle day 2-5)\n\n          -  Antral follicle count (AFC) \u2265 10 to \u226420 follicles with a diameter of <11mm (sum of\n             both ovaries) as measured on ultrasound (US) in the early follicular phase (menstrual\n             cycle day 2-5)\n\n          -  Documented history of infertility due to any of the following factors: tubal factor,\n             mild endometriosis (American Society for Reproductive Medicine [ASRM] stage 1-2),\n             male factor, unexplained infertility\n\n          -  Presence of both ovaries by ultrasonography and normal uterine cavity (confirmed by\n             hysterosalpingography, saline infusion sonography or hysteroscopy within 6 months\n             before randomization)\n\n          -  Male partner with semen analysis that is at least adequate for ICSI within 6 months\n             prior to patient  beginning down-regulation (invasive or surgical sperm retrieval,\n             donor and/or cryopreserved sperm may be used)\n\n          -  Willingness to participate in the study and to comply with the study protocol\n\n          -  Signed informed consent prior to screening\n\n        Exclusion Criteria:\n\n          -  Presence of pregnancy\n\n          -  History of or active polycystic ovary syndrome (PCOS)\n\n          -  AFC >20 follicles with a diameter of <11 mm (both ovaries combined) as measured on US\n             in the early follicular phase (menstrual cycle day 2-5)\n\n          -  History of >2 unsuccessful fresh ART retrieval cycles\n\n          -  Presence of uncontrolled endocrine disorder\n\n          -  Previous history or presence of severe OHSS\n\n          -  Intrauterine fibroids \u22655 cm or otherwise clinically relevant pathology that could\n             impair embryo implantation or pregnancy continuation\n\n          -  History of recurrent spontaneous abortion (3 or more, even when unexplained)\n\n          -  Presence of severe endometriosis (ASRM stage 3 or stage 4) or hydrosalpinx\n\n          -  Neoplasia, including tumors of the hypothalamus and pituitary gland\n\n          -  Abnormal bleeding of undetermined origin\n\n          -  History of extrauterine pregnancy in the previous 3 months\n\n          -  Known allergy or hypersensitivity to progesterone or to any of the excipients\n             (including peanut oil) of the additional study medications (GnRH agonist, Ovidrel\u00ae,\n             and Crinone 8%\u00ae)\n\n          -  History of poor response to gonadotropin treatment (defined as fewer than 5 oocytes\n             retrieved in a previous attempt)\n\n          -  Any hormonal treatment within 1 month before the start of the FSH treatment, with the\n             exception of levothyroxine)\n\n          -  Egg donor\n\n          -  Administration of other investigational products within the previous month\n\n          -  Clinically abnormal findings at Visit 1\n\n          -  Concomitant participation in another study protocol"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "42 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "1106", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01687712", 
            "org_study_id": "FIN3002"
        }, 
        "intervention": [
            {
                "arm_group_label": "Gonal-f RFF", 
                "description": "225IU subcutaneously, starting at the day of successful down-regulation for the first 6 days, followed by a treatment period with an increased dose until the point of ovulation induction has been reached", 
                "intervention_name": "Gonal-f", 
                "intervention_type": "Drug", 
                "other_name": "Follitropin-alfa"
            }, 
            {
                "arm_group_label": "AFOLIA", 
                "description": "225IU subcutaneously, starting at the day of successful down-regulation for the first 6 days, followed by a treatment period with an increased dose until the point of ovulation induction has been reached", 
                "intervention_name": "AFOLIA", 
                "intervention_type": "Drug", 
                "other_name": "Follitropin-alfa"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Follicle Stimulating Hormone"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "IVF", 
            "In vitro fertilization", 
            "Controlled ovarian stimulation", 
            "Follitropin", 
            "AFOLIA", 
            "Finox"
        ], 
        "lastchanged_date": "May 7, 2014", 
        "link": {
            "description": "The IVY Study Website", 
            "url": "http://theivystudy.com/"
        }, 
        "location": [
            {
                "contact": {
                    "email": "r.wallace@atlantishg.com", 
                    "last_name": "Robert Wallace", 
                    "phone": "480-374-7322"
                }, 
                "facility": {
                    "address": {
                        "city": "Tempe", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85284"
                    }, 
                    "name": "Atlantis Global Research Institute"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "samanthav@havingbabies.com", 
                    "last_name": "Samantha Vaughn", 
                    "phone": "818-788-7288", 
                    "phone_ext": "244"
                }, 
                "facility": {
                    "address": {
                        "city": "Encino", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91436"
                    }, 
                    "name": "HRC Fertility"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "gaylec@xxresearch.com", 
                    "last_name": "Gayle Cameron", 
                    "phone": "727-724-9730"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33759"
                    }, 
                    "name": "FL Fertility Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "aroach@ivf.com", 
                    "last_name": "Amy Roach", 
                    "phone": "404-843-2229", 
                    "phone_ext": "105"
                }, 
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30342"
                    }, 
                    "name": "Georgia Reproductive Specialists"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Sue.Jausalitis@integramed.com", 
                    "last_name": "Sue Jausalitis", 
                    "phone": "312-222-8200"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60610"
                    }, 
                    "name": "Fertility Centers of Illinois"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "vkarande@aol.com", 
                    "last_name": "Vishvanath C Karande", 
                    "phone": "847-884-8884", 
                    "phone_ext": "239"
                }, 
                "facility": {
                    "address": {
                        "city": "Hoffman Estates", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60169"
                    }, 
                    "name": "In Via Fertility Specialists"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "elizabeth.oshea@integramed.com", 
                    "last_name": "Elizabeth O'Shea", 
                    "phone": "781-674-1200"
                }, 
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02421"
                    }, 
                    "name": "RSC New England"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "scheibermd@gmail.com", 
                    "last_name": "Michael Scheiber", 
                    "phone": "513-924-5550"
                }, 
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45209"
                    }, 
                    "name": "Institute for Reproductive Health"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "daviese@mainlinefertility.com", 
                    "last_name": "Eileen Davies", 
                    "phone": "484-380-4861"
                }, 
                "facility": {
                    "address": {
                        "city": "Bryn Mawr", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19010"
                    }, 
                    "name": "Mainline Fertility Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "wkutteh@fertilitymemphis.com", 
                    "last_name": "William Kutteh", 
                    "phone": "901-747-2229"
                }, 
                "facility": {
                    "address": {
                        "city": "Memphis", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38120"
                    }, 
                    "name": "Fertility Associates of Memphis"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "tamara@txfertility.com", 
                    "last_name": "Tamara Minter", 
                    "phone": "512-451-7432"
                }, 
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78731"
                    }, 
                    "name": "Texas Fertility Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "LeeAnnH@embryo.net", 
                    "last_name": "Lee Ann Hoffman", 
                    "phone": "817-924-1572"
                }, 
                "facility": {
                    "address": {
                        "city": "Bedford", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75022"
                    }, 
                    "name": "Center for Assisted Reproduction"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "rdunn@fshivf.com", 
                    "last_name": "Randall Dunn", 
                    "phone": "713-512-7891"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77054"
                    }, 
                    "name": "Fertility Specialists of Houston"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kpetermann@hfi-ivf.com", 
                    "last_name": "Karen Petermann", 
                    "phone": "281-554-5111"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77063"
                    }, 
                    "name": "Houston Fertility Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "MFisher@infertilitytexas.com", 
                    "last_name": "Marianne Fisher", 
                    "phone": "281-557-3084"
                }, 
                "facility": {
                    "address": {
                        "city": "Webster", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77598"
                    }, 
                    "name": "Center of Reproducitve Medicine"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "RossBK@EVMS.EDU", 
                    "last_name": "Barbara Ross", 
                    "phone": "757-446-8929"
                }, 
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23507"
                    }, 
                    "name": "Jones Institute for Reproductive Medicine"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase III Investigator- and Assessor-blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA Pen vs. Gonal-f\u00ae RFF Pen) in Normal Ovulatory Women 35 to 42 Years of Age Undergoing in Vitro Fertilization (IVF)", 
        "overall_contact": {
            "email": "mfloyd@lsmgrp.com", 
            "last_name": "Mike Floyd", 
            "phone": "301 651 4256"
        }, 
        "overall_official": {
            "affiliation": "Center for Assisted Reproduction, Bedford, Texas", 
            "last_name": "Kevin Doody, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Clinical pregnancy is defined as presence of a gestational sac and fetal heart activity beginning at six weeks post embryo transfer", 
            "measure": "Clinical pregnancy", 
            "safety_issue": "No", 
            "time_frame": "Six weeks post embryo transfer"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01687712"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measurement of possible antibodies against exogenous r-hFSH", 
                "measure": "Immunogenicity", 
                "safety_issue": "Yes", 
                "time_frame": "Measurement at baseline, 8, 21 and 60 days after start of r-hFSH therapy"
            }, 
            {
                "description": "Evaluation of possible local adverse events due to subcutaneous injections, such as erythema, hematoma, induration etc. using a patient diary. Assessment of systemic adverse events incl. ovarian hyperstimulation syndrome (OHSS) by physical examination and laboratory assessments.", 
                "measure": "Local and systemic adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Systemic adverse events: Screening visit until approx. 40 weeks after the confirmation of biochemical pregnancy. Local adverse events: up to a max. of 16 days after the start of the FSH treatment"
            }, 
            {
                "description": "Follow-up of ongoing pregnancy from date of confirmation of clinical pregnancy until birth including neonatal phase of 28 days", 
                "measure": "Pregnancy outcome", 
                "safety_issue": "Yes", 
                "time_frame": "Follow-up period starting the time of confirmation of clinical pregnancy until 40 weeks after confirmation of biochemical pregnancy (birth)"
            }
        ], 
        "source": "Finox AG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Finox AG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}